patient
recruit
qualifi
studi
typic
cdg
maximum
tcell
count
naiv
cell
absent
prolif
respons
pha
patient
atyp
cdg
less
naiv
cell
addit
least
follow
featur
congenit
heart
diseas
hypoparathyroid
hemizygos
delet
charg
syndrom
patient
detail
see
method
section
articl
onlin
repositori
wwwjacionlineorg
patient
typic
cdg
without
clonal
expans
given
immunosuppress
atyp
cdg
cyclosporin
use
transplant
control
inflammatori
diseas
continu
transplant
patient
also
treat
dose
mgkg
bodi
weight
rabbit
antithymocyt
globulin
atg
genzym
cambridg
mass
mgkg
methylprednisolon
administ
intraven
day
follow
mgkg
oral
prednisolon
day
detail
includ
screen
donor
transplant
procedur
describ
see
method
section
articl
onlin
repositori
separ
thymus
cultur
specif
analysi
assess
cellular
composit
chang
period
cultur
detail
method
see
method
section
articl
onlin
repositori
flow
cytometr
analysi
mitogen
respons
measur
tcell
receptor
signal
joint
excis
circl
trec
level
involv
standard
method
describ
method
section
articl
onlin
repositori
test
possibl
donor
tcell
engraft
short
tandem
repeat
use
previous
describ
clonal
cell
assess
use
chain
spectratyp
popul
previous
regulatori
treg
cell
number
measur
popul
use
intracellular
stain
forkhead
box
spectratyp
also
perform
treg
cell
popul
purifi
mean
cell
sort
base
cell
compar
remain
cell
assess
treg
cell
function
total
cell
isol
cell
studi
cytotox
antigen
upregul
transendocytosi
base
previous
report
modifi
run
assay
period
rather
hour
fixingpermeabil
cell
allow
stain
total
rather
cycl
surfac
frequenc
cell
respons
either
autolog
thirdparti
ebvtransform
lymphoblastoid
cell
line
lcl
stimul
assess
pbmc
use
elispot
assay
previous
histolog
studi
perform
formalinfix
tissu
includ
immunohistochem
analysi
use
standard
method
describ
detail
antibodi
use
given
method
section
articl
onlin
repositori
studi
approv
institut
child
health
great
ormond
street
hospit
research
ethic
committe
cover
thymu
donat
includ
screen
donor
transplant
procedur
recipi
thymic
cultur
undertaken
licens
uk
human
tissu
author
detail
patient
includ
genet
defect
comorbid
infect
acquir
transplant
shown
tabl
median
age
transplant
month
rang
month
case
molecular
basi
dg
undefin
although
one
case
put
mutat
found
analysi
perform
professor
klau
schwartz
univers
ulm
ulm
germani
neither
patient
infant
diabet
mother
atyp
cdg
case
outnumb
typic
case
ratio
evid
bcgassoci
diseas
recipi
vaccin
two
patient
hypothyroid
transplant
caus
establish
neg
test
result
thyroid
peroxisom
antibodi
one
low
thyroidstimul
hormon
valu
suggest
possibl
central
caus
wherea
problem
prove
transient
patient
clearcut
autoimmun
diseas
transplant
period
thymic
cultur
progress
lymphoid
cell
deplet
reciproc
increas
proport
epitheli
cell
adhes
molecul
epcam
thymic
epitheli
cell
tec
fig
ac
small
fraction
cell
remain
predomin
singleposit
cell
fig
could
induc
activ
prolifer
fig
e
f
histolog
section
thymic
slice
cultur
confirm
lymphoid
deplet
although
persist
lymphoid
cell
could
seen
preserv
network
epithelium
seen
cytokeratin
ck
stain
stain
predominantli
medullari
thymic
epitheli
cell
mtec
stain
mtec
cortic
thymic
epitheli
cell
ctec
data
shown
see
fig
articl
onlin
repositori
wwwjacionlineorg
three
patient
second
transplant
skin
rash
earli
week
transplant
underw
skin
biopsi
show
nonspecif
dermat
similar
spongiot
dermat
previous
describ
case
donor
dna
could
detect
skin
blood
patient
patient
abl
clear
rang
infecti
agent
transplant
includ
present
acquir
transplant
tabl
ii
case
receiv
bcg
vaccin
transplant
local
sever
inflammatori
respons
inocul
site
region
lymph
node
tcell
reconstitut
occur
primari
ebv
infect
occur
month
transplant
abl
clear
infect
although
lowlevel
ebv
viremia
persist
month
clear
receiv
chronic
immunosuppress
manag
clear
number
viral
infect
form
autoimmun
complic
occur
patient
surviv
month
tabl
ii
took
one
form
earli
onset
evid
tcell
immun
reconstitut
onset
tcell
reconstitut
detail
autoimmuneinflammatori
complic
patient
provid
result
section
articl
onlin
repositori
see
tabl
articl
onlin
repositori
wwwjacionlineorg
two
case
earlyonset
categori
hemolyt
anemia
respond
treatment
recur
patient
autoimmun
problem
occur
time
tcell
reconstitut
compris
mainli
cytopenia
thyroid
latter
associ
presenc
antithyroid
peroxisom
antibodi
number
transient
autoimmuneinflammatori
phenomena
also
occur
patient
soon
immun
reconstitut
possibl
identifi
associ
develop
autoimmun
methodolog
factor
includ
choic
thymu
donor
thymic
cultur
medium
use
amount
tissu
transplant
use
atg
condit
six
patient
surviv
month
partial
hla
match
loci
resolut
type
see
tabl
articl
onlin
repositori
wwwjacionlineorg
patient
without
autoimmun
complic
fell
group
match
also
develop
autoimmun
although
one
transient
earli
hemolysi
patient
without
hla
match
experienc
autoimmun
one
transient
earli
hemolysi
trend
toward
less
autoimmun
presenc
hla
match
statist
signific
fisher
exact
test
donor
leukocyt
engraft
detect
patient
circul
tcell
number
surviv
patient
increas
around
month
naiv
cell
increas
around
month
transplant
fig
correl
naiv
cell
number
determin
use
differ
flow
cytometr
strategi
shown
fig
articl
onlin
repositori
wwwjacionlineorg
gener
cell
number
achiev
reach
normal
agerel
rang
see
tabl
articl
onlin
repositori
wwwjacionlineorg
continu
increas
naiv
cell
number
month
mainten
rel
steadi
level
low
number
cell
like
caus
immunosuppress
patient
receiv
longterm
immunosuppress
trec
show
similar
time
cours
naiv
cell
fig
rel
poor
correl
trec
naiv
cell
count
see
fig
normal
tcr
divers
demonstr
spectratyp
cell
achiev
patient
includ
atyp
cdg
abnorm
spectratyp
transplant
see
fig
articl
onlin
repositori
wwwjacionlineorg
abnorm
spectratyp
persist
patient
analysi
show
normal
spectratyp
wherea
spectratyp
abnorm
mitogen
respons
pha
fig
b
improv
patient
decreas
immunosuppress
unknown
reason
never
normal
patient
good
evid
thymopoiesi
biopsi
blood
analysi
primari
ebv
infect
pbmc
patient
show
abil
produc
good
respons
autolog
ebvtransform
lcl
respond
significantli
less
well
thirdparti
lcl
fig
c
phenotyp
circul
cell
marker
treg
cell
perform
patient
show
cell
present
low
absolut
number
although
express
proport
cell
differ
healthi
age
control
group
fig
b
see
fig
articl
onlin
repositori
wwwjacionlineorg
proport
treg
cell
respect
wherea
control
subject
median
level
rang
function
abil
cell
patient
term
upregul
activ
transendocytosi
compar
adult
control
sampl
fig
c
see
fig
articl
onlin
repositori
wwwjacionlineorg
spectratyp
perform
sort
treg
cell
show
divers
repertoir
see
fig
articl
onlin
repositori
wwwjacionlineorg
correl
found
level
immunolog
reconstitut
achiev
factor
relat
choic
thymu
donor
thymic
cultur
medium
use
amount
tissu
transplant
use
atg
condit
patient
receiv
immunoglobulin
replac
transplant
five
patient
stop
immunoglobulin
around
month
transplant
per
protocol
normal
igg
level
date
patient
immun
tetanu
toxoid
show
protect
respons
three
receiv
conjug
pneumococc
vaccin
made
good
protect
respons
one
patient
respond
vaccin
reimmun
iga
level
undetectableextrem
low
transplant
patient
low
gl
level
normal
transplant
survivor
except
bcell
number
remain
normal
see
fig
articl
onlin
repositori
wwwjacionlineorg
patient
except
receiv
treatment
mab
rituximab
proport
b
cell
classswitch
memori
b
cell
test
patient
valu
remain
rel
low
compar
publish
agerel
control
patient
wherea
other
within
normal
limit
particularli
year
see
fig
b
biopsi
transplant
thymic
slice
undertaken
patient
includ
transplant
median
time
month
rang
month
transplant
area
histolog
normal
thymic
tissu
seen
muscl
includ
corticomedullari
distinct
hassal
bodi
format
biopsi
specimen
biopsi
specimen
immunohistochem
stain
show
abund
cell
evid
cortic
thymopoiesi
defin
express
termin
deoxynucleotidyl
transferas
normal
matur
late
mtec
stage
defin
express
claudin
autoimmun
regul
air
involucrin
stain
show
presenc
frequent
posit
cell
fig
see
fig
articl
onlin
repositori
wwwjacionlineorg
biopsi
specimen
case
show
less
welldevelop
thymic
architectur
definit
evid
cortic
thymopoiesi
defin
presenc
cortic
thymocyt
data
shown
biopsi
specimen
evid
thymopoiesi
found
first
transplant
like
biopsi
specimen
miss
thymu
muscl
later
appear
thymic
emigr
blood
indic
thymopoiesi
die
cmv
biopsi
specimen
taken
month
show
viabl
thymic
epithelium
littl
thymopoiesi
see
fig
ad
articl
onlin
repositori
wwwjacionlineorg
cmv
could
demonstr
thymic
tissu
data
shown
die
earli
transplant
postmortem
examin
transplant
thymu
reveal
viabl
epithelium
extens
neovascular
see
fig
e
f
studi
show
transplant
cultur
thymic
epithelium
reconstitut
tcell
immun
patient
cdg
enabl
control
opportunist
infect
qualiti
life
restrict
suscept
infect
confirm
add
result
previous
report
surviv
rate
level
immun
reconstitut
achiev
similar
seri
proport
children
autoimmun
complic
higher
present
studi
number
rel
small
difficult
know
whether
differ
signific
present
studi
novel
data
document
chang
cellular
composit
thymic
slice
cultur
provid
well
data
trec
level
achiev
number
phenotyp
function
treg
cell
also
detail
histolog
evid
thymic
biopsi
specimen
confirm
full
matur
mtec
although
patient
studi
recogn
genet
caus
dg
previou
studi
includ
number
case
includ
matern
diabet
show
patient
equival
outcom
level
tcell
reconstitut
achiev
surviv
patient
usual
normal
age
suffici
allow
clearanc
viral
infect
case
normal
mitogen
respons
achiev
divers
repertoir
demonstr
tcr
spectratyp
circul
treg
cell
could
detect
proport
similar
control
children
although
lower
absolut
number
function
shown
normal
apart
one
case
respons
ebv
shown
antigenspecif
tcell
respons
assay
studi
respons
studi
tetanu
candida
speci
antigen
previou
seri
show
posit
respons
surviv
patient
followup
year
abl
stop
immunoglobulin
test
thu
far
normal
antibodi
respons
tetanu
normal
antibodi
respons
conjug
pneumococc
vaccin
iga
defici
correct
patient
number
classswitch
memori
b
cell
remain
rel
low
patient
assess
signific
find
longer
followup
need
determin
whether
proport
increas
time
reason
suboptim
number
cell
achiev
patient
clear
could
insuffici
thymic
tissu
transplant
fact
correl
studi
north
american
amount
tissu
transplant
eventu
tcell
naiv
tcell
count
achiev
associ
count
type
medium
use
cultur
use
atg
presenc
chanc
overlap
hla
antigen
donor
recipi
shown
cultur
thymu
lose
lymphoid
cell
popul
cultur
rel
enrich
tec
howev
viabl
lymphoid
cell
capabl
prolifer
still
present
cell
might
necessari
mainten
growth
theoret
cell
could
mediat
graftversushost
diseas
seen
blood
analysi
engraft
donor
hematopoiet
cell
detect
patient
one
situat
thymopoiesi
might
develop
context
preexist
cmv
infect
seen
studi
previou
find
viabl
thymic
epithelium
thymopoiesi
biopsi
consist
possibl
viru
agent
use
treat
might
inhibit
develop
thymopoiesi
children
cdg
complic
cmv
infect
surviv
either
previou
studi
biopsi
transplant
thymu
shown
help
determin
whether
thymopoiesi
report
biopsi
done
around
month
transplant
posit
result
show
evid
cortic
thymopoiesi
half
thymic
medulla
hassal
corpuscl
present
studi
biopsi
done
later
median
month
posit
result
clear
corticomedullari
differenti
develop
hassal
corpuscl
immunohistochem
evid
differenti
mtec
proce
termin
stage
like
differ
time
biopsi
account
differ
previou
seri
present
previou
seri
autoimmun
complic
rel
common
predominantli
involv
thyroid
cytopenia
complic
transient
natur
might
reflect
immun
dysregul
tcell
reconstitut
sometim
seen
clinic
situat
hsct
experiment
two
earli
case
autoimmun
seen
tcell
emerg
could
conceiv
noth
transplant
reason
suscept
autoimmun
complic
poorli
understood
possibl
inadequ
neg
select
mtec
contribut
develop
autoimmun
support
find
previou
larger
benefici
effect
chanc
partial
hla
match
conclus
studi
strengthen
case
thymu
transplant
correct
treatment
choic
cdg
offer
possibl
immun
reconstitut
degre
produc
qualiti
life
limit
infect
suscept
autoimmun
common
complic
often
manag
rel
easili
proport
children
experi
seriou
consequ
work
requir
understand
better
pathogenesi
problem
newborn
screen
program
scid
expand
patient
might
requir
treatment
work
need
streamlin
laborintens
process
requir
special
facil
gener
transplant
thymu
model
human
thymu
transplant
nude
mous
might
use
explor
patient
might
benefit
approach
includ
infant
scid
immun
reconstitut
hsct
gene
therapi
thymic
insufficiencyclin
implicationsthymu
transplant
treatment
choic
infant
cdg
except
possibl
sever
preexist
viral
infect
risk
autoimmun
complic
signific
issu
survivor
work
need
understand
better
